{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:47:47Z","timestamp":1790473667999,"version":"4.1.0"},"reference-count":92,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:00:00Z","timestamp":1484265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Allergy and Infectious Diseases (US)","award":["R21 AI101170"],"award-info":[{"award-number":["R21 AI101170"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0170240","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T18:35:57Z","timestamp":1484332557000},"page":"e0170240","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus)"],"prefix":"10.1371","volume":"12","author":[{"given":"Cordelia","family":"Manickam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Wachtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Martinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis D.","family":"Giavedoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Keith","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/hep.1840360704","article-title":"Course and outcome of hepatitis C","volume":"36","author":"JH Hoofnagle","year":"2002","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2014.7085","article-title":"Treatment of hepatitis C: a systematic review","volume":"312","author":"A Kohli","year":"2014","journal-title":"JAMA"},{"issue":"Suppl 4","key":"ref3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jvh.12475","article-title":"Historical epidemiology of hepatitis C virus (HCV) in select countries\u2014volume 3","volume":"22","author":"V Liakina","year":"2015","journal-title":"J Viral Hepat"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"R Lozano","year":"2012","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MAJ.0b013e31828b25a5","article-title":"Association between metabolic syndrome and its individual components with viral hepatitis B","volume":"347","author":"R Jinjuvadia","year":"2014","journal-title":"Am J Med Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s10620-015-3983-3","article-title":"Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review","volume":"61","author":"HK Dyal","year":"2016","journal-title":"Dig Dis Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/07315724.2015.1072756","article-title":"Factors Associated with Insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without Obesity or Type 2 Diabetes","volume":"35","author":"LP Oliveira","year":"2016","journal-title":"J Am Coll Nutr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.14218\/JCTH.2015.00051","article-title":"Hepatitis C Virus, Insulin Resistance, and Steatosis","volume":"4","author":"D Kralj","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.3748\/wjg.v20.i23.7089","article-title":"Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen","volume":"20","author":"A Lonardo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jhep.2003.11.004","article-title":"The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients","volume":"40","author":"HM Patton","year":"2004","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2893.2011.01555.x","article-title":"Steatosis is the predictor of relapse in HCV genotype 3- but not 2-infected patients treated with 12 weeks of pegylated interferon-alpha-2a plus ribavirin and RVR","volume":"19","author":"L Restivo","year":"2012","journal-title":"J Viral Hepat"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.hepres.2006.02.001","article-title":"Hepatic steatosis is a predictor of poor response to interferon alpha-2b and ribavirin combination therapy in Japanese patients with chronic hepatitis C","volume":"35","author":"R Yaginuma","year":"2006","journal-title":"Hepatol Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S1542-3565(05)00246-6","article-title":"Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C","volume":"3","author":"SA Harrison","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/viro.2001.0892","article-title":"Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites","volume":"283","author":"S Lee","year":"2001","journal-title":"Virology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00705-013-1892-3","article-title":"Hepatitis C virus nonstructural protein 5A favors upregulation of gluconeogenic and lipogenic gene expression leading towards insulin resistance: a metabolic syndrome","volume":"159","author":"F Parvaiz","year":"2014","journal-title":"Arch Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1099\/vir.0.83491-0","article-title":"Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2","volume":"89","author":"JK Oem","year":"2008","journal-title":"J Gen Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1096\/fj.01-0396com","article-title":"Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis","volume":"16","author":"G Perlemuter","year":"2002","journal-title":"FASEB J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.2006.02729.x","article-title":"Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection","volume":"23","author":"A de Gottardi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"26602","DOI":"10.1074\/jbc.M601284200","article-title":"Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance","volume":"281","author":"N Kamei","year":"2006","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm724","article-title":"Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30","volume":"8","author":"N Maeda","year":"2002","journal-title":"Nat Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.dsx.2012.08.011","article-title":"Visfatin and its role in obesity development","volume":"6","author":"J Stastny","year":"2012","journal-title":"Diabetes Metab Syndr"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/MEG.0b013e32835f2726","article-title":"Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4","volume":"25","author":"Y Saad","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1158\/1055-9965.EPI-14-0161","article-title":"Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan","volume":"23","author":"CL Chen","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2337\/diabetes.53.7.1773","article-title":"Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity","volume":"53","author":"AJ Hanley","year":"2004","journal-title":"Diabetes"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1172\/JCI10583","article-title":"Cellular mechanisms of insulin resistance","volume":"106","author":"GI Shulman","year":"2000","journal-title":"J Clin Invest"},{"issue":"Suppl 3","key":"ref27","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/sj.ijo.0802502","article-title":"Inflammatory pathways and insulin action","volume":"27","author":"GS Hotamisligil","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/ijms17030355","article-title":"Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection\u2014Liver: The &quot;Musketeer&quot; in the Spotlight","volume":"17","author":"S Ballestri","year":"2016","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(78)90131-9","article-title":"Transmissible agent in non-A, non-B hepatitis","volume":"1","author":"HJ Alter","year":"1978","journal-title":"Lancet"},{"issue":"Suppl 1","key":"ref30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1478-3231.2008.01925.x","article-title":"Discovery of the hepatitis C virus","volume":"29","author":"M Houghton","year":"2009","journal-title":"Liver Int"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/hep.20268","article-title":"A critical role for the chimpanzee model in the study of hepatitis C","volume":"39","author":"J Bukh","year":"2004","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S1474-4422(04)00879-8","article-title":"Modelling of multiple sclerosis: lessons learned in a non-human primate","volume":"3","author":"BA t Hart","year":"2004","journal-title":"Lancet Neurol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jmv.2092","article-title":"Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees","volume":"65","author":"J Bukh","year":"2001","journal-title":"J Med Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/viro.1999.9941","article-title":"Toward a surrogate model for hepatitis C virus: An infectious molecular clone of the GB virus-B hepatitis agent","volume":"262","author":"J Bukh","year":"1999","journal-title":"Virology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1073\/pnas.92.8.3401","article-title":"Identification of two flavivirus-like genomes in the GB hepatitis agent","volume":"92","author":"JN Simons","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1128\/JVI.69.9.5621-5630.1995","article-title":"Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis","volume":"69","author":"AS Muerhoff","year":"1995","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00000441-197507000-00011","article-title":"Hepatitis in marmosets","volume":"270","author":"F Deinhardt","year":"1975","journal-title":"Am J Med Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/oby.2009.77","article-title":"Characterization of obese phenotypes in a small nonhuman primate, the common marmoset (Callithrix jacchus)","volume":"17","author":"SD Tardif","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/0300985814537839","article-title":"The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"52","author":"JA Kramer","year":"2015","journal-title":"Vet Pathol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"E592","DOI":"10.1002\/oby.20462","article-title":"Metabolic consequences of the early onset of obesity in common marmoset monkeys","volume":"21","author":"ML Power","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/oby.20432","article-title":"Relation of food intake behaviors and obesity development in young common marmoset monkeys","volume":"21","author":"CN Ross","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"ref42","article-title":"Acute liver damage associated with innate immune activation in a small nonhuman primate model of Hepacivirus infection","author":"C Manickam","year":"2016","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2005.03.015","article-title":"Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology","volume":"301","author":"LD Giavedoni","year":"2005","journal-title":"Journal of Immunological Methods"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0042-6822(03)00193-4","article-title":"Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia","volume":"311","author":"RE Lanford","year":"2003","journal-title":"Virology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/JVI.78.4.2062-2071.2004","article-title":"Development of a GB virus B marmoset model and its validation with a novel series of hepatitis C virus NS3 protease inhibitors","volume":"78","author":"H Bright","year":"2004","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/JVI.00033-09","article-title":"The marmoset model of GB virus B infections: adaptation to host phenotypic variation","volume":"83","author":"T Weatherford","year":"2009","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1365-2036.2006.03114.x","article-title":"Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin\/tumour necrosis factor-alpha in chronic hepatitis C patients","volume":"24","author":"E Durante-Mangoni","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.arcmed.2009.04.008","article-title":"Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis","volume":"40","author":"A Tiftikci","year":"2009","journal-title":"Arch Med Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1111\/j.1365-2893.2011.01516.x","article-title":"Serum PAI-1 is a novel predictor for response to pegylated interferon-alpha-2b plus ribavirin therapy in chronic hepatitis C virus infection","volume":"19","author":"D Miki","year":"2012","journal-title":"J Viral Hepat"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0950-3536(89)80007-1","article-title":"Viruses and bone marrow failure","volume":"2","author":"G Kurtzman","year":"1989","journal-title":"Baillieres Clin Haematol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1096-9071(19971003)53:2<182::AID-JMV12>3.0.CO;2-L","article-title":"Hepatitis C virus-induced leuko-thrombocytopenia and haemolysis","volume":"53","author":"G Emilia","year":"1997","journal-title":"J Med Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1365-2141.2000.02132.x","article-title":"HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant alpha2b-interferon therapy","volume":"110","author":"J Garcia-Suarez","year":"2000","journal-title":"Br J Haematol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1742-1241.2003.tb11390.x","article-title":"Thrombocytopenia in patients with HCV-positive chronic hepatitis: efficacy of leucocyte interferon-alpha treatment","volume":"57","author":"A Benci","year":"2003","journal-title":"Int J Clin Pract"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1086\/423384","article-title":"Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection","volume":"39","author":"CS Wang","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80021-3","article-title":"Thrombocytopenia associated with hepatitis C viral infection","volume":"24","author":"T Nagamine","year":"1996","journal-title":"J Hepatol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","article-title":"Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance","volume":"126","author":"Y Shintani","year":"2004","journal-title":"Gastroenterology"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/gut.2004.050302","article-title":"Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C","volume":"54","author":"L Fartoux","year":"2005","journal-title":"Gut"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1034\/j.1600-0676.2003.00841.x","article-title":"Insulin resistance\/beta-cell function and serum ferritin level in non-diabetic patients with hepatitis C virus infection","volume":"23","author":"M Furutani","year":"2003","journal-title":"Liver Int"},{"key":"ref59","first-page":"468","article-title":"Glucagon and insulin metabolism in cirrhotic patients","volume":"45","author":"T Yoshida","year":"1998","journal-title":"Hepatogastroenterology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1530\/EJE-11-0765","article-title":"Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in metabolic syndrome","volume":"166","author":"S Calanna","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2337\/db07-1124","article-title":"Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance","volume":"57","author":"K Vollmer","year":"2008","journal-title":"Diabetes"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"E318","DOI":"10.1152\/ajpendo.00191.2010","article-title":"GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet","volume":"299","author":"ET Parlevliet","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4254\/wjh.v3.i5.99","article-title":"Insulin resistance and chronic liver disease","volume":"3","author":"T Kawaguchi","year":"2011","journal-title":"World J Hepatol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1440-1746.2007.05183.x","article-title":"Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance","volume":"23","author":"M Itou","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"ref65","first-page":"365","article-title":"Clinical and histological aspects of chronic HCV infection and cirrhosis","volume":"40","author":"G Giusti","year":"1993","journal-title":"Hepatogastroenterology"},{"issue":"Suppl 2","key":"ref66","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1478-3231.2008.01950.x","article-title":"Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data","volume":"29","author":"F Negro","year":"2009","journal-title":"Liver Int"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000007778","article-title":"Severity of HCV-induced liver damage alters glucose homeostasis in noncirrhotic patients with chronic HCV infection","volume":"62","author":"T Konrad","year":"2000","journal-title":"Digestion"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","article-title":"Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease","volume":"126","author":"A Lonardo","year":"2004","journal-title":"Gastroenterology"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1440-1746.2001.02407.x","article-title":"Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation","volume":"16","author":"SJ Hwang","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jcp.31.8.772","article-title":"Serum total lipids, lipoprotein cholesterol, and apolipoprotein A in acute viral hepatitis and chronic liver disease","volume":"31","author":"C Vergani","year":"1978","journal-title":"J Clin Pathol"},{"key":"ref71","first-page":"217","article-title":"Serum lipids and lipoproteins in chronic liver disease","volume":"33","author":"J Feher","year":"1976","journal-title":"Acta Med Acad Sci Hung"},{"key":"ref72","first-page":"436","article-title":"Serum cholesterol and chronic hepatitis C","volume":"28","author":"G Maggi","year":"1996","journal-title":"Ital J Gastroenterol"},{"key":"ref73","article-title":"Infection of common marmosets with hepatitis C virus\/GB virus-B chimeras","author":"T Li","year":"2013","journal-title":"Hepatology"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.hepres.2005.09.023","article-title":"Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH","volume":"33","author":"K Koike","year":"2005","journal-title":"Hepatol Res"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2004.12.049","article-title":"Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients","volume":"128","author":"M Romero-Gomez","year":"2005","journal-title":"Gastroenterology"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2003-031005","article-title":"Adipocytokines and insulin resistance","volume":"89","author":"AG Pittas","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1043-2760(00)00301-5","article-title":"Adipose tissue as an endocrine organ","volume":"11","author":"RS Ahima","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"e37412","DOI":"10.5812\/hepatmon.37412","article-title":"The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease","volume":"16","author":"R Jamali","year":"2016","journal-title":"Hepat Mon"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000314592","article-title":"Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C","volume":"83","author":"A Baranova","year":"2011","journal-title":"Digestion"},{"issue":"Suppl","key":"ref80","first-page":"S11","article-title":"Plasminogen activator inhibitor-1 and diabetic nephropathy","volume":"10","author":"HB Lee","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"ref81","article-title":"Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy","author":"IB Kolseth","year":"2016","journal-title":"J Diabetes Complications"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.27664","article-title":"Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans","volume":"61","author":"MZ Molnar","year":"2015","journal-title":"Hepatology"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.03710708","article-title":"Hepatitis C infection and chronic renal diseases","volume":"4","author":"N Perico","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/039139881203500901","article-title":"The evidence-based epidemiology of HCV-associated kidney disease","volume":"35","author":"F Fabrizi","year":"2012","journal-title":"Int J Artif Organs"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.etp.2006.05.001","article-title":"Renal dysfunction as a consequence of acute liver damage by bile duct ligation in cirrhotic rats","volume":"58","author":"S Rivera-Huizar","year":"2006","journal-title":"Exp Toxicol Pathol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/jmp.12134","article-title":"Spontaneous glomerular mesangial lesions in common marmoset monkeys (Callithrix jacchus): a benign non-progressive glomerulopathy","volume":"43","author":"MG Collins","year":"2014","journal-title":"J Med Primatol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1439-0442.1990.tb00963.x","article-title":"IgM nephropathy (nephritis) in clawed monkeys (Primates, Anthropoidea, Platyrrhina, Callithricidae)","volume":"37","author":"M Brack","year":"1990","journal-title":"Zentralbl Veterinarmed A"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1177\/0300985811427151","article-title":"Spontaneous glomerular and tubulointerstitial lesions in common marmosets (Callithrix jacchus)","volume":"49","author":"K Isobe","year":"2012","journal-title":"Vet Pathol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2169\/internalmedicine.40.1109","article-title":"Polymyositis, pulmonary fibrosis and malignant lymphoma associated with hepatitis C virus infection","volume":"40","author":"Y Aisa","year":"2001","journal-title":"Intern Med"},{"key":"ref90","first-page":"197","article-title":"HCV and dermatomyositis: report of 5 cases of dermatomyositis in patients with HCV infection","volume":"18","author":"G Fiore","year":"1996","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"ref91","first-page":"834","article-title":"Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma","volume":"27","author":"KM Kee","year":"2004","journal-title":"Chang Gung Med J"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/PL00007437","article-title":"Hepatitis C virus infection and myositis: a polymerase chain reaction study","volume":"99","author":"M Villanova","year":"2000","journal-title":"Acta Neuropathol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0170240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T18:59:16Z","timestamp":1692644356000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0170240"}},"subtitle":[],"editor":[{"given":"Gualtiero","family":"Alvisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0170240","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,13]]}}}